{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:52:43Z","timestamp":1793307163576,"version":"4.5.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/1673-5374.262599","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:25:33Z","timestamp":1565169933000},"page":"2156","source":"Crossref","is-referenced-by-count":46,"title":["Relationship between high dietary fat intake and Parkinson\u2019s disease risk: a meta-analysis"],"prefix":"10.4103","volume":"14","author":[{"given":"Qiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Man","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.262599-1","doi-asserted-by":"crossref","unstructured":"Akbar M, Kim HY (2002) Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 82:655-665.","DOI":"10.1046\/j.1471-4159.2002.01015.x"},{"key":"key-10.4103\/1673-5374.262599-2","doi-asserted-by":"crossref","unstructured":"Akbar M, Calderon F, Wen Z, Kim HY (2005) Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A 102:10858-10863.","DOI":"10.1073\/pnas.0502903102"},{"key":"key-10.4103\/1673-5374.262599-3","doi-asserted-by":"crossref","unstructured":"Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, Spencer B, Masliah E (2008) Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson\u2019s disease. J Neurochem 105:1656-1667.","DOI":"10.1111\/j.1471-4159.2008.05254.x"},{"key":"key-10.4103\/1673-5374.262599-4","doi-asserted-by":"crossref","unstructured":"Bousquet M, St-Amour I, Vandal M, Julien P, Cicchetti F, Calon F (2012) High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice. Neurobiol Dis 45:529-538.","DOI":"10.1016\/j.nbd.2011.09.009"},{"key":"key-10.4103\/1673-5374.262599-5","doi-asserted-by":"crossref","unstructured":"Bowen RA, Clandinin MT (2002) Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. J Neurochem 83:764-774.","DOI":"10.1046\/j.1471-4159.2002.01156.x"},{"key":"key-10.4103\/1673-5374.262599-6","doi-asserted-by":"crossref","unstructured":"Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N, Jr., Frautschy SA, Cole GM (2005) Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer\u2019s disease. Eur J Neurosci 22:617-626.","DOI":"10.1111\/j.1460-9568.2005.04253.x"},{"key":"key-10.4103\/1673-5374.262599-7","doi-asserted-by":"crossref","unstructured":"Chaturvedi S, Ostbye T, Stoessl AJ, Merskey H, Hachinski V (1995) Environmental exposures in elderly Canadians with Parkinson\u2019s disease. Can J Neurol Sci 22:232-234.","DOI":"10.1017\/S0317167100039901"},{"key":"key-10.4103\/1673-5374.262599-8","doi-asserted-by":"crossref","unstructured":"Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Dietary intakes of fat and risk of Parkinson\u2019s disease. Am J Epidemiol 157:1007-1014.","DOI":"10.1093\/aje\/kwg073"},{"key":"key-10.4103\/1673-5374.262599-9","doi-asserted-by":"crossref","unstructured":"Choi JY, Jang EH, Park CS, Kang JH (2005) Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic Biol Med 38:806-816.","DOI":"10.1016\/j.freeradbiomed.2004.12.008"},{"key":"key-10.4103\/1673-5374.262599-10","doi-asserted-by":"crossref","unstructured":"Cota GF, de Sousa MR, Fereguetti TO, Rabello A (2013) Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison. PLoS Negl Trop Dis 7:e2195.","DOI":"10.1371\/journal.pntd.0002195"},{"key":"key-10.4103\/1673-5374.262599-11","doi-asserted-by":"crossref","unstructured":"Dalfo E, Portero-Otin M, Ayala V, Martinez A, Pamplona R, FeORer I (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64:816-830.","DOI":"10.1097\/01.jnen.0000179050.54522.5a"},{"key":"key-10.4103\/1673-5374.262599-12","doi-asserted-by":"crossref","unstructured":"de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM (2005) Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 64:2040-2045.","DOI":"10.1212\/01.WNL.0000166038.67153.9F"},{"key":"key-10.4103\/1673-5374.262599-13","doi-asserted-by":"crossref","unstructured":"Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson\u2019s disease. Neurotoxicology 23:487-502.","DOI":"10.1016\/S0161-813X(02)00099-2"},{"key":"key-10.4103\/1673-5374.262599-14","doi-asserted-by":"crossref","unstructured":"Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Counsell C, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A, Geoparkinson study (2007) Environmental risk factors for Parkinson\u2019s disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64:666-672.","DOI":"10.1136\/oem.2006.027003"},{"key":"key-10.4103\/1673-5374.262599-15","doi-asserted-by":"crossref","unstructured":"Dong J, Beard JD, Umbach DM, Park Y, Huang X, Blair A, Kamel F, Chen H (2014) Dietary fat intake and risk for Parkinson\u2019s disease. Mov Disord 29:1623-1630.","DOI":"10.1002\/mds.26032"},{"key":"key-10.4103\/1673-5374.262599-16","doi-asserted-by":"crossref","unstructured":"Fabelo N, Martin V, Santpere G, Marin R, ToORent L, FeORer I, Diaz M (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol Med 17:1107-1118.","DOI":"10.2119\/molmed.2011.00119"},{"key":"key-10.4103\/1673-5374.262599-17","doi-asserted-by":"crossref","unstructured":"Fang X, An P, Wang H, Wang X, Shen X, Li X, Min J, Liu S, Wang F (2015) Dietary intake of heme iron and risk of cardiovascular disease: a dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis 25:24-35.","DOI":"10.1016\/j.numecd.2014.09.002"},{"key":"key-10.4103\/1673-5374.262599-18","doi-asserted-by":"crossref","unstructured":"Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, Ascherio A (2007) Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 86:1486-1494.","DOI":"10.1093\/ajcn\/86.5.1486"},{"key":"key-10.4103\/1673-5374.262599-19","doi-asserted-by":"crossref","unstructured":"Hadders-Algra M (2008) Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J Perinat Med 36:101-109.","DOI":"10.1515\/JPM.2008.029"},{"key":"key-10.4103\/1673-5374.262599-20","doi-asserted-by":"crossref","unstructured":"Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer\u2019s disease model rats. J Neurochem 81:1084-1091.","DOI":"10.1046\/j.1471-4159.2002.00905.x"},{"key":"key-10.4103\/1673-5374.262599-21","doi-asserted-by":"crossref","unstructured":"Hellenbrand W, Boeing H, Robra BP, Seidler A, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G (1996) Diet and Parkinson\u2019s disease. II: a possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 47:644-650.","DOI":"10.1212\/WNL.47.3.644"},{"key":"key-10.4103\/1673-5374.262599-22","doi-asserted-by":"crossref","unstructured":"Ikemoto A, Ohishi M, Sato Y, Hata N, Misawa Y, Fujii Y, Okuyama H (2001) Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42:1655-1663.","DOI":"10.1016\/S0022-2275(20)32220-3"},{"key":"key-10.4103\/1673-5374.262599-23","doi-asserted-by":"crossref","unstructured":"Jenner P (2003) Oxidative stress in Parkinson\u2019s disease. Ann Neurol 53 Suppl 3:S26-36.","DOI":"10.1002\/ana.10483"},{"key":"key-10.4103\/1673-5374.262599-24","doi-asserted-by":"crossref","unstructured":"Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, MaORas C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM (2014) Dietary fat intake, pesticide use, and Parkinson\u2019s disease. Parkinsonism Relat Disord 20:82-87.","DOI":"10.1016\/j.parkreldis.2013.09.023"},{"key":"key-10.4103\/1673-5374.262599-25","doi-asserted-by":"crossref","unstructured":"Kirkey KL, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Gorell JM (2001) Occupational categories at risk for Parkinson\u2019s disease. Am J Ind Med 39:564-571.","DOI":"10.1002\/ajim.1055"},{"key":"key-10.4103\/1673-5374.262599-26","doi-asserted-by":"crossref","unstructured":"Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A (2013) Dietary and lifestyle variables in relation to incidence of Parkinson\u2019s disease in Greece. Eur J Epidemiol 28:67-77.","DOI":"10.1007\/s10654-012-9760-0"},{"key":"key-10.4103\/1673-5374.262599-27","doi-asserted-by":"crossref","unstructured":"Laye S (2010) Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot Essent Fatty Acids 82:295-303.","DOI":"10.1016\/j.plefa.2010.02.006"},{"key":"key-10.4103\/1673-5374.262599-28","doi-asserted-by":"crossref","unstructured":"Levant B, Ozias MK, Carlson SE (2007) Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J Nutr 137:130-134.","DOI":"10.1093\/jn\/137.1.130"},{"key":"key-10.4103\/1673-5374.262599-29","doi-asserted-by":"crossref","unstructured":"Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B (2005) Evaluation of epidemiologic and animal data associating pesticides with Parkinson\u2019s disease. J Occup Environ Med 47:1059-1087.","DOI":"10.1097\/01.jom.0000174294.58575.3e"},{"key":"key-10.4103\/1673-5374.262599-30","doi-asserted-by":"crossref","unstructured":"Liu Q, Xu Y, Wan W, Ma Z (2018) An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice. J Neural Transm (Vienna) 125:203-210.","DOI":"10.1007\/s00702-017-1819-3"},{"key":"key-10.4103\/1673-5374.262599-31","doi-asserted-by":"crossref","unstructured":"Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R (1996) Dietary lipids and antioxidants in Parkinson\u2019s disease: a population-based, case-control study. Ann Neurol 39:89-94.","DOI":"10.1002\/ana.410390113"},{"key":"key-10.4103\/1673-5374.262599-32","unstructured":"Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, Lojacono N, Cote L, Mayeux R (1998) Dietary iron, animal fats, and risk of Parkinson\u2019s disease. Mov Disord 13:13-16."},{"key":"key-10.4103\/1673-5374.262599-33","doi-asserted-by":"crossref","unstructured":"Ma ZG, Xu J, Liu TW (2015) Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C\/G polymorphism and the risk of sporadic Parkinson\u2019s diseases: a meta-analysis. Neurol Sci 36:47-51.","DOI":"10.1007\/s10072-014-1884-4"},{"key":"key-10.4103\/1673-5374.262599-34","doi-asserted-by":"crossref","unstructured":"Ma ZG, Liu TW, Bo YL (2015) HLA-DRA rs3129882 A\/G polymorphism was not a risk factor for Parkinson\u2019s disease in Chinese-based populations: a meta-analysis. Int J Neurosci 125:241-246.","DOI":"10.3109\/00207454.2014.926349"},{"key":"key-10.4103\/1673-5374.262599-35","doi-asserted-by":"crossref","unstructured":"Ma ZG, He F, Xu J (2015) Quantitative assessment of the association between GAK rs1564282 C\/T polymorphism and the risk of Parkinson\u2019s disease. J Clin Neurosci 22:1077-1080.","DOI":"10.1016\/j.jocn.2014.12.014"},{"key":"key-10.4103\/1673-5374.262599-36","doi-asserted-by":"crossref","unstructured":"Martin MG, Pfrieger F, Dotti CG (2014) Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep 15:1036-1052.","DOI":"10.15252\/embr.201439225"},{"key":"key-10.4103\/1673-5374.262599-37","doi-asserted-by":"crossref","unstructured":"Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson\u2019s Disease Study G (2010) Dietary fat intake and risk of Parkinson\u2019s disease: a case-control study in Japan. J Neurol Sci 288:117-122.","DOI":"10.1016\/j.jns.2009.09.021"},{"key":"key-10.4103\/1673-5374.262599-38","doi-asserted-by":"crossref","unstructured":"Martinez B, Peplow PV (2018) Neuroprotection by immunomodulatory agents in animal models of Parkinson\u2019s disease. Neural Regen Res 13:1493-1506.","DOI":"10.4103\/1673-5374.237108"},{"key":"key-10.4103\/1673-5374.262599-39","doi-asserted-by":"crossref","unstructured":"Noguchi N, Saito Y, Urano Y (2014) Diverse functions of 24(S)-hydroxycholesterol in the brain. Biochem Biophys Res Commun 446:692-696.","DOI":"10.1016\/j.bbrc.2014.02.010"},{"key":"key-10.4103\/1673-5374.262599-40","doi-asserted-by":"crossref","unstructured":"Noseworthy MD, Bray TM (1998) Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic Biol Med 24:942-951.","DOI":"10.1016\/S0891-5849(97)00383-3"},{"key":"key-10.4103\/1673-5374.262599-41","doi-asserted-by":"crossref","unstructured":"Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, PeORy G, Thal LJ, Sano M, Refolo LM (2002) Cholesterol, oxidative stress, and Alzheimer\u2019s disease: expanding the horizons of pathogenesis. Free Radic Biol Med 33:173-181.","DOI":"10.1016\/S0891-5849(02)00841-9"},{"key":"key-10.4103\/1673-5374.262599-42","doi-asserted-by":"crossref","unstructured":"Pirchl M, Ullrich C, Sperner-Unterweger B, Humpel C (2012) Homocysteine has anti-inflammatory properties in a hypercholesterolemic rat model in vivo. Mol Cell Neurosci 49:456-463.","DOI":"10.1016\/j.mcn.2012.03.001"},{"key":"key-10.4103\/1673-5374.262599-43","doi-asserted-by":"crossref","unstructured":"Porter NA, Caldwell SE, Mills KA (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30:277-290.","DOI":"10.1007\/BF02536034"},{"key":"key-10.4103\/1673-5374.262599-44","doi-asserted-by":"crossref","unstructured":"Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Jr., Swanson PD, Checkoway H (2009) Dietary fats, cholesterol and iron as risk factors for Parkinson\u2019s disease. Parkinsonism Relat Disord 15:47-52.","DOI":"10.1016\/j.parkreldis.2008.03.002"},{"key":"key-10.4103\/1673-5374.262599-45","doi-asserted-by":"crossref","unstructured":"Prasanthi JR, Dasari B, Marwarha G, Larson T, Chen X, Geiger JD, Ghribi O (2010) Caffeine protects against oxidative stress and Alzheimer\u2019s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 49:1212-1220.","DOI":"10.1016\/j.freeradbiomed.2010.07.007"},{"key":"key-10.4103\/1673-5374.262599-46","doi-asserted-by":"crossref","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson\u2019s disease: a metaanalysis. Environ Res 86:122-127.","DOI":"10.1006\/enrs.2001.4264"},{"key":"key-10.4103\/1673-5374.262599-47","doi-asserted-by":"crossref","unstructured":"Sampaio TB, Savall AS, Gutierrez MEZ, Pinton S (2017) Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s diseases: implications for pathogenesis and therapy. Neural Regen Res 12:549-557.","DOI":"10.4103\/1673-5374.205084"},{"key":"key-10.4103\/1673-5374.262599-48","doi-asserted-by":"crossref","unstructured":"Schapira AH (2007) Mitochondrial dysfunction in Parkinson\u2019s disease. Cell Death Differ 14:1261-1266.","DOI":"10.1038\/sj.cdd.4402160"},{"key":"key-10.4103\/1673-5374.262599-49","doi-asserted-by":"crossref","unstructured":"Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154:1119-1125.","DOI":"10.1093\/aje\/154.12.1119"},{"key":"key-10.4103\/1673-5374.262599-50","doi-asserted-by":"crossref","unstructured":"Shchepinov MS, Chou VP, Pollock E, Langston JW, Cantor CR, Molinari RJ, Manning-Bog AB (2011) Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson\u2019s disease. Toxicol Lett 207:97-103.","DOI":"10.1016\/j.toxlet.2011.07.020"},{"key":"key-10.4103\/1673-5374.262599-51","doi-asserted-by":"crossref","unstructured":"Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70:560S-569S.","DOI":"10.1093\/ajcn\/70.3.560s"},{"key":"key-10.4103\/1673-5374.262599-52","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012.","DOI":"10.1001\/jama.283.15.2008"},{"key":"key-10.4103\/1673-5374.262599-53","doi-asserted-by":"crossref","unstructured":"Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH (1999) Environmental, medical, and family history risk factors for Parkinson\u2019s disease: a New England-based case control study. Am J Med Genet 88:742-749.","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#"},{"key":"key-10.4103\/1673-5374.262599-54","doi-asserted-by":"crossref","unstructured":"Thirumangalakudi L, Prakasam A, Zhang R, Bimonte-Nelson H, Sambamurti K, Kindy MS, Bhat NR (2008) High cholesterol-induced neuroinflammation and amyloid precursor protein processing coORelate with loss of working memory in mice. J Neurochem 106:475-485.","DOI":"10.1111\/j.1471-4159.2008.05415.x"},{"key":"key-10.4103\/1673-5374.262599-55","doi-asserted-by":"crossref","unstructured":"Ullrich C, Pirchl M, Humpel C (2010) Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol Cell Neurosci 45:408-417.","DOI":"10.1016\/j.mcn.2010.08.001"},{"key":"key-10.4103\/1673-5374.262599-56","doi-asserted-by":"crossref","unstructured":"Vance JE (2012) Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech 5:746-755.","DOI":"10.1242\/dmm.010124"},{"key":"key-10.4103\/1673-5374.262599-57","doi-asserted-by":"crossref","unstructured":"Wang QM, Xu YY, Liu S, Ma ZG (2017) Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice. Oncotarget 8:47284-47295.","DOI":"10.18632\/oncotarget.17618"},{"key":"key-10.4103\/1673-5374.262599-58","doi-asserted-by":"crossref","unstructured":"Wullner U, Klockgether T (2003) Inflammation in Parkinson\u2019s disease. J Neurol 250 Suppl 1:I35-I38.","DOI":"10.1007\/s00415-003-1107-x"},{"key":"key-10.4103\/1673-5374.262599-59","doi-asserted-by":"crossref","unstructured":"Youdim KA, Martin A, Joseph JA (2000) Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci 18:383-399.","DOI":"10.1016\/S0736-5748(00)00013-7"},{"key":"key-10.4103\/1673-5374.262599-60","doi-asserted-by":"crossref","unstructured":"Zecca L, Youdim MB, Riederer P, Connor JR, Crichton OR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873.","DOI":"10.1038\/nrn1537"},{"key":"key-10.4103\/1673-5374.262599-61","doi-asserted-by":"crossref","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk? (1998) A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690-1691.","DOI":"10.1001\/jama.280.19.1690"},{"key":"key-10.4103\/1673-5374.262599-62","doi-asserted-by":"crossref","unstructured":"Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R (2002) Familial and environmental risk factors in Parkinson\u2019s disease: a case-control study in north-east Italy. Acta Neurol Scand 105:77-82.","DOI":"10.1034\/j.1600-0404.2002.1o040.x"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:29Z","timestamp":1786732649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.262599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"alternative-id":["262599"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.262599","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}